Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID-19 pandemic era in China.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0391 (Electronic) Linking ISSN: 10550496 NLM ISO Abbreviation: Am J Addict Subsets: MEDLINE
    • Publication Information:
      Publication: Oxford : Wiley-Blackwell
      Original Publication: Washington, DC : American Psychiatric Press, c1992-
    • Subject Terms:
      Behavior, Addictive*/epidemiology ; COVID-19* ; Education, Nursing, Baccalaureate* ; Students, Nursing*; China/epidemiology ; Cross-Sectional Studies ; Humans ; Internet ; Internet Use ; Pandemics ; Prevalence ; Quality of Life ; SARS-CoV-2
    • Abstract:
      Background and Objectives: The prevalence of problematic Internet use (PIU) in the post-COVID-19 pandemic era is not known. This cross-sectional study aimed to determine the prevalence of PIU among baccalaureate nursing students (hereafter: nursing students) in the post-COVID-19 era.
      Methods: A total of 1070 nursing students were consecutively invited to participate in this study from the nursing schools of five universities. PIU and quality of life (QOL) were assessed using the Internet Addiction Test (IAT) and the World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF), respectively. t Tests, χ 2 , tests, and Kruskal-Wallis tests were used to compare basic demographic and clinical characteristics between participants with and without PIU. Binary logistic regression analysis was used to examine independent correlates.
      Results: The prevalence of PIU was 23.3% (95% confidence interval [CI]: 20.7%-25.8%). Multiple logistic regression analysis revealed that second- (p = .024) and third-year (p = .012) students were more likely to suffer from PIU compared with first year students. Students with more severe depressive (p = .014) and anxiety symptoms (p = .011) were independently and significantly associated with more severe PIU. After controlling for covariates, nursing students with PIU had a lower overall QOL score (p = .002).
      Conclusion and Scientific Significance: Problematic Internet use (PIU) was common among nursing students in the post-COVID-19 era. Considering the negative impact of PIU on QOL and academic performance, regular screening should be conducted and effective interventions implemented for nursing students with PIU. This was the first study on the prevalence of PIU among nursing students in the post-COVID-19 era. The findings of this study could help health professionals and education authorities to understand the patterns of PIU and its influence on QOL among nursing students and to allocate health resources and develop effective measures to reduce the risk of PIU in this population.
      (© 2021 American Academy of Addiction Psychiatry.)
    • References:
      Int Braz J Urol. 2020 Jul;46(suppl.1):120-124. (PMID: 32550706)
      Asia Pac Psychiatry. 2021 Jun;13(2):e12406. (PMID: 32783389)
      Cyberpsychol Behav. 2008 Oct;11(5):571-6. (PMID: 18785835)
      Asia Pac Psychiatry. 2020 Jun;12(2):e12387. (PMID: 32286004)
      Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. (PMID: 22588748)
      Acad Psychiatry. 2018 Feb;42(1):88-93. (PMID: 28849574)
      J Adolesc Health. 2009 Jun;44(6):598-605. (PMID: 19465325)
      Brain Sci. 2020 Jun 03;10(6):. (PMID: 32503172)
      Int J Environ Res Public Health. 2020 Mar 06;17(5):. (PMID: 32155789)
      Cyberpsychol Behav Soc Netw. 2011 Dec;14(12):741-6. (PMID: 21651418)
      Eat Weight Disord. 2016 Dec;21(4):709-717. (PMID: 27757931)
      Pediatrics. 2017 Nov;140(Suppl 2):S76-S80. (PMID: 29093037)
      J Neurosci Rural Pract. 2021 Jan;12(1):67-70. (PMID: 33531762)
      Neurosci Biobehav Rev. 2017 May;76(Pt A):174-184. (PMID: 28027952)
      Cyberpsychol Behav Soc Netw. 2014 Nov;17(11):720-8. (PMID: 25405785)
      Health Qual Life Outcomes. 2019 Apr 17;17(1):67. (PMID: 30995918)
      Sleep Med. 2020 Nov;75:315-325. (PMID: 32950013)
      J Sleep Res. 2021 Aug;30(4):e13259. (PMID: 33417262)
      Am J Drug Alcohol Abuse. 2010 Sep;36(5):277-83. (PMID: 20545603)
      J Sleep Res. 2016 Aug;25(4):458-65. (PMID: 26854132)
      Curr Pharm Des. 2014;20(25):4026-52. (PMID: 24001297)
      J Affect Disord. 2021 Mar 1;282:33-38. (PMID: 33387744)
      PLoS One. 2016 Sep 12;11(9):e0161126. (PMID: 27618306)
      Eur Psychiatry. 2012 Jan;27(1):1-8. (PMID: 22153731)
      J Addict Med. 2014 Jul-Aug;8(4):282-7. (PMID: 25026104)
      CNS Spectr. 2016 Apr;21(2):207-13. (PMID: 26268304)
      Sci Rep. 2020 Oct 1;10(1):16222. (PMID: 33004842)
      BMC Psychiatry. 2014 Jun 20;14:183. (PMID: 24947851)
      Transl Psychiatry. 2020 Oct 2;10(1):337. (PMID: 33009366)
      Qual Life Res. 2004 Mar;13(2):299-310. (PMID: 15085902)
      J Glob Health. 2020 Dec;10(2):020319. (PMID: 33110521)
      Eur J Public Health. 2006 Oct;16(5):536-41. (PMID: 16524936)
      J Epidemiol. 2017 Mar;27(3):107-111. (PMID: 28142042)
      Addict Behav. 2020 Feb;101:105962. (PMID: 31030950)
      J Pediatr Psychol. 2013 Aug;38(7):794-807. (PMID: 23671059)
      J Behav Addict. 2017 Sep 1;6(3):267-270. (PMID: 28033714)
      Eur J Psychotraumatol. 2020 Jul 7;11(1):1769379. (PMID: 33029315)
      JAMA Psychiatry. 2019 Jan 1;76(1):21-30. (PMID: 30264137)
      Comput Inform Nurs. 2011 Nov;29(11):657-61. (PMID: 21697708)
      Med Care. 2008 Mar;46(3):266-74. (PMID: 18388841)
      Asian J Psychiatr. 2017 Aug;28:15-20. (PMID: 28784371)
      J Sleep Res. 2011 Jun;20(2):311-7. (PMID: 20819144)
      Pediatrics. 1999 Sep;104(3):e27. (PMID: 10469810)
      Public Health. 2015 Sep;129(9):1224-36. (PMID: 26343546)
      Compr Psychiatry. 2020 Jul;100:152180. (PMID: 32422427)
      Sleep. 2004 Feb 1;27(1):101-4. (PMID: 14998244)
      Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788. (PMID: 32526627)
      Am J Addict. 2020 Jul;29(4):268-270. (PMID: 32500608)
      Psychosom Med. 2021 May 1;83(4):373-379. (PMID: 32815855)
      Curr Psychiatry Rev. 2012 Nov;8(4):292-298. (PMID: 23125561)
      PLoS One. 2020 Apr 16;15(4):e0231924. (PMID: 32298385)
      J Med Internet Res. 2020 Jun 17;22(6):e20185. (PMID: 32519963)
      Asia Pac Psychiatry. 2013 Dec;5(4):316-21. (PMID: 23857796)
      Cyberpsychol Behav Soc Netw. 2014 Dec;17(12):755-60. (PMID: 25489876)
      J Affect Disord. 2020 Sep 1;274:576-582. (PMID: 32663990)
      Brain Behav Immun. 2020 Jul;87:40-48. (PMID: 32298802)
      PLoS One. 2018 Jun 26;13(6):e0197562. (PMID: 29944668)
      Am J Addict. 2021 Nov;30(6):585-592. (PMID: 34532935)
      Lancet. 2020 Mar 14;395(10227):912-920. (PMID: 32112714)
      J Behav Addict. 2018 Sep 1;7(3):610-623. (PMID: 30010411)
      Asia Pac Psychiatry. 2017 Dec;9(4):. (PMID: 29193712)
      Sci Rep. 2021 Feb 12;11(1):3735. (PMID: 33580190)
      PLoS One. 2016 Mar 15;11(3):e0151042. (PMID: 26978264)
      Med Care. 2003 Nov;41(11):1284-92. (PMID: 14583691)
      Br J Psychiatry. 2010 Jun;196(6):486-92. (PMID: 20513862)
    • Grant Information:
      2018ZX09201-014 National Science and Technology Major Project for Investigational New Drugs; Z181100001518005 Beijing Municipal Science & Technology Commission; 2020 Higher Education Teaching Achievement Cultivation Project of Gansu Province; MYRG2019-00066-FHS University of Macau
    • Publication Date:
      Date Created: 20210917 Date Completed: 20211125 Latest Revision: 20211211
    • Publication Date:
      20221213
    • Accession Number:
      PMC8652965
    • Accession Number:
      10.1111/ajad.13216
    • Accession Number:
      34532935